Articles citing Frontiers

Cannabis for Mood Disorder Relief

3 Sources

There has been a growing interest in the potential benefits of cannabis for individuals experiencing mood disorders. With research evolving and public perception shifting, cannabis is increasingly recognized not just for its recreational uses but also for its therapeutic potential. This story synthesizes insights from significant studies.

Read article
Promising Results for Pain and Neuroprotection

2 Sources

Studies indicate that cannabinoids may significantly alleviate chronic pain and enhance neuroprotection, expanding cannabis use in medical care.

Read article

Sources from Frontiers

CB1R expression in brain and spinal cord regions, with levels from low to high in green.

Frontiers Frontiers

Cited in: Promising Results for Pain and Neuroprotection

Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment

26min read

Despite the importance of pain as a warning physiological system, chronic neuropathic pain is frequently caused by damage in the nervous system, followed by persistence over a long period, even in the absence of dangerous stimuli or after healing of injuries.

Flowchart of study selection for qualitative synthesis: 3,262 records identified, 78 studies included, with exclusion reasons.

Frontiers Frontiers

Cited in: Cannabis for Mood Disorder Relief

Cannabis use and mood disorders: a systematic review

24min read

Problematic cannabis use is highly prevalent among people with mood disorders. This underscores the need to understand the effects of cannabis and cannabinoids in this population, especially considering legalization of recreational cannabis use.

Abstract close-up of glowing blue lines radiating from a bright central core on a dark background, resembling a neuron or a burst of energy, with small orange nodes scattered along the filaments.

Frontiers Frontiers

The Emerging Role of Endocannabinoids in Synaptic Plasticity, Reward, and Addiction | Frontiers Research Topic

0min read

Endocannabinoids (eCBs) regulate behavior through the central nervous system, particularly in reward and addiction pathways. While they influence synaptic plasticity, the exact mechanisms remain unclear. Emerging tech, like optogenetics, helps study eCB function.